The US Food and Drug Administration on Wednesday approved a cancer drug developed by China-based Akeso Inc, marking a ...

A federal court in Houston unsealed a five‑count indictment charging a Venezuelan man with terrorism‑related crimes — the ...

NurExone's ExoTherapy platform enables precise, minimally-invasive delivery of therapies to injured tissues using exosomes as an advanced delivery system. With a growing body of preclinical data and ...

Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") , a clinical-stage biotechnology company leveraging its proprietary DiffuSpheretm technology designed to optimize drug delivery for ...

Leaders from around the Sahtu region gathered in Fort Good Hope, N.W.T., this week to discuss the impacts of the drug crisis ...

Pharmacy benefit managers (PBMs) are up to bat in the perpetual blame game between PBMs and the pharmaceutical industry. | ...

BioAtla (BCAB) announced preclinical poster presentations at the upcoming 2025 American Association for Cancer Research to be held at the ...

A copy of the presentation materials can be accessed on the “ Publication ” section of the Company’s website at www.bioatla.com once the presentations have concluded.

Receiving a generic version of Ozempic or Wegovy from a compounding pharmacy is normally both easier to access and cheaper.

While much of the conversation around the Trump administration’s potential pharmaceutical import tariffs has leaned heavily ...

Additionally, as previously announced, an oral presentation regarding Emi-Le will be given at the ESMO Breast Cancer 2025 Annual Congress in Munich, Germany on Thursday, May 15, 2025. This ...